Connect with us

Hi, what are you looking for?

Thursday, Jul 23, 2026
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Orla Mining and Equinox Gold shareholders approve their merger
Orla Mining and Equinox Gold shareholders approve their merger
At Orla's Musselwhite Mine, Ontario, Canada. Photo credit: Orla Mining

Gold

Orla Mining and Equinox Gold shareholders approve their merger

It will create Canada’s second largest gold producer behind Agnico Eagle

Following Equinox Gold Corp‘s (TSE: EQX) (NYSEAMERICAN: EQX) (FRA: 1LRC) expansion into Central America and Newfoundland via its takeover of Calibre Mining, the company is advancing its portfolio with another significant acquisition.

Equinox shareholders approved the proposed business combination with Orla Mining Ltd (TSE: OLA) (NYSEAMERICAN: ORLA) (FRA: O8M) at a special meeting on Jul. 22. Orla securityholders also voted in favour of the merger on the same day. The transaction now awaits final court approval, with closing anticipated around Jul. 31.

Once finalised, Equinox shareholders will hold approximately 67 per cent ownership of the combined company and Orla shareholders about 33 per cent.

Equinox will acquire Orla’s operating assets and development projects. The most prominent addition is the Musselwhite underground gold mine in northwestern Ontario, which has operated for over 25 years and produced more than 6 million ounces of gold to date. Orla also contributes the Camino Rojo gold and silver open-pit mine in Mexico and the feasibility-stage South Railroad project in Nevada on the Carlin trend.

The enlarged group will rank as the second-largest gold producer in Canada after Agnico Eagle Mines Ltd (TSE: AEM) (NYSE: AEM) (FRA: AE9), supported by output from Musselwhite alongside Equinox’s existing Canadian operations.

Read more: Strategic U.S. antimony resource emerges in NevGold’s Nevada MRE

Operational outlook post-merger

Public materials from both companies describe a combined portfolio that produces roughly 1.1 million ounces of gold annually, with potential to reach more than 1.9 million ounces through several organic projects. These include expansions at Valentine in Newfoundland, South Railroad in Nevada, and further development at sites such as Castle Mountain, Los Filos and Camino Rojo underground.

The companies highlight complementary assets across North America and a strengthened balance sheet for funding growth. Presentations note opportunities for free cash flow generation and reserve expansion, though execution risks common to the mining sector remain. Key specific risks include integrating two workforces, advancing South Railroad through feasibility without cost overruns and sustaining grades at Musselwhite, where deeper mining has historically raised costs.

Overall, the transaction aims to create a larger entity with greater diversification while maintaining focus on tier-one jurisdictions where possible.

“Together we’ll accelerate into being a senior producer much more quickly than we could have done apart,” said Equinox CEO Darren Hall in May when the deal was being organised, “and that’s the value proposition in a nutshell.”

Gold prices have recovered somewhat after earlier losses. The metal reached record highs above US$5,500 per ounce intraday in late January  before declining below US$4,000 per ounce in late June. Spot prices have since traded in the US$4,120 to US4,150 range in mid-to-late July amid ongoing market volatility and geopolitical turmoil.

Read more: NevGold Corp. reports antimony grades up to 53.7 per cent at Nevada project

 

Follow Mugglehead on X

Like Mugglehead on Facebook

Follow Rowan Dunne on X

Follow Rowan Dunne on LinkedIn

rowan@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Medical and Pharmaceutical

The pivotal agreement is valued at up to US$100 million

Technology

It aims to eventually expand into multiple critical infrastructure applications

Mining

Trench samples returned exceptional grades up to 23% Sb

Medical and Pharmaceutical

Freenome has been developing its blood biopsy platform for more than a decade